(Q28271405)

https://api.crossref.org/works/10.1038/ONC.2009.518

Stops along the RAS pathway in human genetic disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Copy number variation at 1q21.1 associated with neuroblastoma

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Activating mutations in ALK provide a therapeutic target in neuroblastoma

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

The epidemiology of neuroblastoma: a review

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Identification of ALK as a major familial neuroblastoma predisposition gene

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Anaplastic lymphoma kinase: signalling in development and disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

In Vitro studies of non poly alanine PHOX2B mutations argue against a loss-of-function mechanism for congenital central hypoventilation

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.518

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Cancer. Addiction to oncogenes--the Achilles heal of cancer

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Transcriptional regulation and transformation by Myc proteins

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Chromosome 1p and 11q deletions and outcome in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Cholinergic switch associated with morphological differentiation in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Neuroblastoma: biological insights into a clinical enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Oncogenic mutations of ALK kinase in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

The anaplastic lymphoma kinase in the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Clinical and molecular aspects of RAS related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

A proposed staging for children with neuroblastoma.Children's cancer study group A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

High-resolution mapping of amplicons of the short arm of chromosome 1 in two neuroblastoma tumors by microarray-based comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Exploration of human miRNA target genes in neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Preferential occurrence of chromosome breakpoints within early replicating regions in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Overall genomic pattern is a predictor of outcome in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Coamplification of the L-myc and N-myc oncogenes in a neuroblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Altered expression of cell cycle genes distinguishes aggressive neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Prognostic significance of DNA di-tetraploidy in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Expression of the ALK tyrosine kinase gene in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Double-strand break repair in the absence of RAD51 in yeast: a possible role for break-induced DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Genotype-phenotype correlations in MYCN-related Feingold syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Screening for neuroblastoma: a resurrected idea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Chronic myeloid leukaemia as a model of disease evolution in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Reflecting on 25 years with MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

ArrayCGH-based classification of neuroblastoma into genomic subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

High-resolution detection and mapping of genomic DNA alterations in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Germline PHOX2B mutation in hereditary neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Biological role of anaplastic lymphoma kinase in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Prevalence and functional consequence of PHOX2B mutations in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Neuroblastoma-remembering the three physicians who described it a century ago: James Homer Wright, William Pepper, and Robert Hutchison

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Neuroblastoma Screening at One Year of Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Combined 24-color karyotyping and comparative genomic hybridization analysis indicates predominant rearrangements of early replicating chromosome regions in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Variety and complexity of chromosome 17 translocations in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

MYCN regulates oncogenic MicroRNAs in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

A mouse model for EML4-ALK-positive lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Molecular consequences of PHOX2B missense, frameshift and alanine expansion mutations leading to autonomic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Translocation-excision-deletion-amplification mechanism leading to nonsyntenic coamplification of MYC and ATBF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

The Myc oncoprotein as a therapeutic target for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

The MYCN oncogene is a direct target of miR-34a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Targeted expression of MYCN causes neuroblastoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

A Case of a Diffuse Large B-Cell Lymphoma of Plasmablastic Type Associated With the t(2;5)(p23;q35) Chromosome Translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Treatment complications in children diagnosed with neuroblastoma during a screening program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

High incidence of DNA mutations and gene amplifications of theALKgene in advanced sporadic neuroblastoma tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Characterization of amplicons in neuroblastoma: High-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Analysis of candidate gene co-amplification with MYCN in neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Two distinct deleted regions on the short arm of chromosome I in neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institut Gustave-Roussy in France

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

The Phox2B homeobox gene is mutated in sporadic neuroblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.518